KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guardant Health (GH) Enterprise Value: 2017-2025

Historic Enterprise Value for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to $7.2 billion.

  • Guardant Health's Enterprise Value rose 274.36% to $7.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 billion, marking a year-over-year increase of 518.60%. This contributed to the annual value of $2.9 billion for FY2024, which is 45.06% up from last year.
  • Per Guardant Health's latest filing, its Enterprise Value stood at $7.2 billion for Q3 2025, which was up 23.95% from $5.8 billion recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Enterprise Value peaked at $13.4 billion during Q1 2021, and registered a low of $1.3 billion during Q1 2024.
  • Its 3-year average for Enterprise Value is $3.2 billion, with a median of $2.9 billion in 2024.
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 80.78% in 2022, then surged by 274.36% in 2025.
  • Over the past 5 years, Guardant Health's Enterprise Value (Quarterly) stood at $9.2 billion in 2021, then tumbled by 80.78% to $1.8 billion in 2022, then climbed by 13.97% to $2.0 billion in 2023, then surged by 45.06% to $2.9 billion in 2024, then soared by 274.36% to $7.2 billion in 2025.
  • Its Enterprise Value was $7.2 billion in Q3 2025, compared to $5.8 billion in Q2 2025 and $4.6 billion in Q1 2025.